Page last updated: 2024-11-13
doxycycline hyclate
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
Tetraclean: antibiotic-based product for root canal irrigation to remove both the microorganisms and the smear layer present in the root canals; contains cetrimide (Cetrimonium Compounds) [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
| ID Source | ID |
|---|---|
| PubMed CID | 54686183 |
| CHEMBL ID | 3989740 |
| MeSH ID | M0104501 |
Synonyms (87)
| Synonym |
|---|
| vibravenos |
| tetradox |
| azudoxat |
| spanor |
| retens |
| mespafin |
| ronaxan |
| lymepak (tn) |
| doxy |
| periostat (tn) |
| vibra-tabs (tn) |
| D02129 |
| doryx (tn) |
| doxycycline hydrochloride hydrate (jp17) |
| doxycycline hyclate (usp) |
| doxy 100 |
| atridox |
| doxy-lemmon |
| 6-deoxy-5-hydroxytetracycline hydrochloride hemihydrate |
| doxy 200 |
| vivox |
| vibra-tabs |
| periostat |
| 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide monohydrochloride, compound with ethyl alcohol (2:1), monohydrate |
| doryx |
| doxychel hyclate |
| doxycycline hyclate (internal use) |
| (4s,4ar,5s,5ar,6r,12as)-4-(dimethylamino)-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide - ethanol (2:1) dihydrochloride hydrate |
| AC-6017 |
| nsc-741421 |
| S4163 |
| nsc 741421 |
| doryx mpc |
| tetraclean |
| dentista |
| doxycycline hyclate [usan:usp] |
| unii-19xts3t51u |
| acticlate |
| wc 2031 |
| 19xts3t51u , |
| doxteric |
| acticlate cap |
| monodoks |
| doxyprex |
| doxycycline hyclate [ep impurity] |
| doxycyclini hyclas [who-ip latin] |
| doxycycline hyclate [ep monograph] |
| lymepak |
| doxycycline hyclate [usp-rs] |
| doxycycline hydrochloride hemiethanolate hemihydrate [mi] |
| doxycycline hyclate [usp monograph] |
| unacil |
| doxycycline hyclate [who-ip] |
| vibraveineuse |
| doxycycline hyclate [vandf] |
| doxicrisol |
| duradoxal |
| doxycycline hydrochloride hydrate [jan] |
| zadorin |
| doxylar |
| granudoxy |
| doxycycline hyclate [who-dd] |
| doxycycline hyclate [orange book] |
| doxycycline hyclate [green book] |
| diocimex |
| clinofug |
| AKOS025402170 |
| (4s,4ar,5s,5ar,6r,12ar)-4-(dimethylamino)-1,5,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4a,5,5a,6-tetrahydro-4h-tetracene-2-carboxamide;ethanol;hydrate;dihydrochloride |
| wc2031 |
| EN300-379220 |
| bis((4s,4ar,5s,5ar,6r,12as)-4-(dimethylamino)-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide) ethanol hydrate dihydrochloride |
| Z2791720087 |
| (4s,4ar,5s,5ar,6r,12as)-4-(dimethylamino)-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide compound with ethanol (2:1) dihydrochloride hydrate |
| CHEMBL3989740 |
| doxycyclini hyclas |
| doxycycline hydrochloride hydrate |
| SW219440-2 |
| SW219440-1 |
| DS-9077 |
| doxycycline, hyclate - cas 24390-14-5 |
| Q27116248 |
| doxycycline hyclate 100 microg/ml in acetonitrile |
| AMY32700 |
| CCG-270611 |
| doxycycline hyclate is known as a broad-spectrum tetracycline antibiotic. |
| BD166236 |
| AKOS040742632 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (8)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 8 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
Market Indicators
Research Demand Index: 126.79
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.
| This Compound (126.79) All Compounds (24.57) |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 3 (25.00%) | 5.53% |
| Reviews | 2 (16.67%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 7 (58.33%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||